How will my solution be evaluated?

Solve’s unique selection methodology is a multi-phase process that includes screening, review, and judging. Expert panels of judges utilize evaluation criteria to assign quantitative scores to each solution. These scores, coupled with qualitative deliberation discussion, determine the selection of winning teams.

The scoring rubric uses the below criteria to assess the solutions: 

• Alignment: The solution addresses at least one of the key dimensions of the Challenge.

• Potential for Impact: The planned solution implementation has the potential to positively impact the holistic wellbeing of rare disease patients and their caregivers.

• Feasibility: The team has a realistic and practical plan for implementing the solution, and it is feasible in the given context.

• Innovative Approach: The solution approaches the problem in a new or significantly improved way. Includes a new innovation or technology, a new application of an existing innovation or technology, a new business model, or a new process for solving the challenge.

• Inclusive Human-Centered Design: The solution is designed with and for underserved communities. The solution team demonstrates proximity to the community and both embodies and addresses diversity, equity, and inclusion throughout the design, implementation and internal operations of the solution. Per the eligibility, protected characteristics such as race, color, sex, sexual orientation, gender identity, religion, disability, age, genetic information, veteran status, ancestry, national or ethnic origin will not be a factor in determining whether or not a group is eligible for The Amgen Prize or a factor in awarding The Amgen Prize.

• Scalability: The solution can be scaled to affect the lives of more people within its target population.

• Plan to Leverage Funding: The applicant clearly explains how the solution would benefit from the funding that The Amgen Prize will provide.